It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Companhia Brasileira de Distribuicao (CBD) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $3.10. The Companhia Brasileira de Distribuicao has recorded 1,244 volume in the after hours trading session.
Companhia Brasileira de Distribuicao is listed on the NYSE in the Consumer Cyclical sector while operating in the Department Stores industry. At the end of the last regular session, the stock closed at $3.10 and fluctuated between $3.2000 as its day high and $3.0900 as its day low. The current market capitalization of Companhia Brasileira de Distribuicao is $844.19M. A total of 0.37 million shares were traded on the day, compared to an average of 922.10K shares.
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Companhia Brasileira de Distribuicao pays an annual dividend of $0.07, resulting in a dividend yield of 2.29%, and it has a price to earnings (P/E) ratio of 13.78. CBD’s most recent ex-dividend date was 5/6/2022 when it declared a $0.0610 quarterly dividend that was paid in cash on 6/22/2022. Previously, the company paid the dividend on 6/22/2021 with an ex-dividend date of 5/6/2021. The CBD stock dividend was $0.3997 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for CBD in the last 3 months, the mean price target is $5.12 with high estimates of $7.47 and low estimates of $4.01. In terms of 52-week highs and lows, CBD has a high of $5.50 and a low of $2.73.
As of this writing, CBD has an earnings estimate of -$0.18 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of -$0.18 per share and a lower estimate of -$0.18. The company reported an EPS of $0.99 in the last quarter, which was 1,514.30% higher than expectations of -$0.07.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 11 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CBD is Hold with a score of 4.00. A total of 4 analysts rated the stock as Buy while 0 rated it as Overweight while 6 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 1 thought it should be Sold.